The Weston Family Foundation, through the Weston Brain Institute (the “Institute”), aims to catalyze and scale science-based approaches to significantly improve the health and well-being of Canadians. The Institute is pleased to announce the re-launch of our flagship Rapid Response program, which is designed to provide seed funding to catalyze novel, high-risk, high-reward translational research… Read more »
The Weston Family Foundation, through the Weston Brain Institute (the “Institute”), aims to catalyze and scale science-based approaches to significantly improve the health and well-being of Canadians. The Institute is pleased to announce the re-launch of our flagship Rapid Response program, which is designed to provide seed funding to catalyze novel, high-risk, high-reward translational research… Read more »
Please note: To apply, applicants must submit an LOI to the Foundation. Selected applicants will then be invited to submit a Proposal. The Weston Family Foundation, through the Weston Brain Institute (the “Institute”), aims to catalyze and scale science-based approaches to significantly improve the health and well-being of Canadians. There is growing evidence that making… Read more »
The Weston Brain Institute supports research that accelerates the development of therapeutics for neurodegenerative diseases of aging. To help achieve this, the Institute addresses gaps and inefficiencies in the funding market by supporting high-risk, high-reward translational projects, while leveraging world-class business and scientific expertise in a fast and flexible granting process. Ensuring the world hears… Read more »
Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. Diseases such as Alzheimer’s and Parkinson’s are placing a large and increasing burden on society. If ignored, the social and economic costs of managing these diseases will rise significantly within a generation. Meeting these challenges requires pioneering approaches to accelerating treatments. The Early… Read more »
The Michael J. Fox Foundation and Weston Brain Institute Computational Science Fellowship program is a collaboration between the two organizations with the goal of supporting research that will apply sophisticated computational approaches and expertise to advance therapeutic development for neurodegenerative diseases of aging. Funding Available: Two 18-month fellowships of US$150,000 each for salary support and… Read more »
The Alzheimer’s Association (ALZ), Alzheimer’s Research UK (ARUK), The Michael J. Fox Foundation for Parkinson’s Research (MJFF), and the Weston Brain Institute (Weston) announce a global Request for Applications (RFA). The main objective of BAND is to stimulate analyses across Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases to increase understanding of pathogenesis similarities and differences. The intent of this RFA is to analyze across existing… Read more »
The Alzheimer’s Association (ALZ), Alzheimer’s Research UK (ARUK), The Michael J. Fox Foundation for Parkinson’s Research (MJFF), and the Weston Brain Institute (Weston) announce a global Request for Applications (RFA). The main objective of BAND is to stimulate analyses across Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases to increase understanding of pathogenesis similarities and differences. The intent of this RFA is to analyze across existing… Read more »
With our Adjacent Fields: Canada initiative, we are encouraging applications from fields such as computational neuroscience, data science, engineering, etc., through our Canadian funding programs. These applications must meet our other disease and project scope criteria. Read ‘What we Fund’ here. Expression of particular interest in applications that bring in expertise, technologies, or approaches to… Read more »
The Weston Brain Institute is delighted to launch our International Fellowships: Canada 2018 Program. The program will support top Canadian PhD students to travel to and work in world-renowned international labs for up to 12 months, to further their translational research on neurodegenerative diseases of aging. Program overview Goal: To accelerate the careers of top Canadian PhD students by… Read more »
Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. Based on success of previous programs, the Institute is expanding our support to new formats while maintaining the same… Read more »
Program Overview The Early Phase Clinical Trials program was created to provide significant support for clinical trials and/or clinical trial sub-studies that have excellent preliminary data. Funding Up to $1,500,000 per project over up to 4 years Eligibility Principal applicants must be at or above the level of Assistant Professor or equivalent, and be affiliated… Read more »
This program supports top-tier Canadian postdoctoral scholars by providing international training at the University of Oxford and affiliation with Merton College. Awarded researchers will receive £57,000 per year for 2 years. Prior to submitting an application, candidates should independently identify a host lab and potential supervisor at the University of Oxford who agrees to supervise them… Read more »
Goal: Provide funding for preclinical translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging. Funding: A maximum of $1,500,000 over up to 3 years Eligibility: Researchers at or above the level of Assistant Professor or equivalent are eligible to apply as the Principal Applicant. Collaborators must be at the post-doctoral level or… Read more »